Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$10.29 +4.1%	$11.99	$9.30 ▼ $25.36	$457.35M	1.12	530,691 shs	1.18 million shs
AXGN AxoGen	$13.75 +0.2%	$11.36	$7.83 ▼ $21.00	$624.86M	1	1.67 million shs	3.51 million shs
EDTXF Spectral Diagnostics	$0.61 -1.6%	$0.61	$0.32 ▼ $0.65	$175.72M	0.26	12,515 shs	248 shs
KIDS OrthoPediatrics	$17.90 -11.3%	$21.43	$16.59 ▼ $33.14	$490.35M	1.12	163,269 shs	389,207 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	+3.13%	-11.73%	-13.29%	-18.06%	-55.12%
AXGN AxoGen	+0.22%	+4.17%	+21.04%	+8.86%	+75.61%
EDTXF Spectral Diagnostics	-1.59%	-0.82%	+0.83%	-2.42%	+47.56%
KIDS OrthoPediatrics	-11.34%	-17.44%	-15.73%	-22.44%	-34.34%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS Avanos Medical	1.7184 of 5 stars	0.0	3.0	0.0	1.1	1.7	2.5
AXGN AxoGen	2.2907 of 5 stars	3.5	1.0	0.0	2.2	2.5	0.6
EDTXF Spectral Diagnostics	0.3441 of 5 stars	0.0	3.0	0.0	2.6	0.0	0.0
KIDS OrthoPediatrics	3.8928 of 5 stars	3.4	1.0	3.9	1.8	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	0.00	N/A	N/A	N/A
AXGN AxoGen	3.00	Buy	$24.50	78.18% Upside
EDTXF Spectral Diagnostics	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.86	Moderate Buy	$36.29	102.71% Upside

Current Analyst Ratings Breakdown

Latest EDTXF, AXGN, AVNS, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/6/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $39.00
7/14/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/13/2025	AXGN AxoGen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00

(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$692.50M	0.69	$12.40 per share	0.83	$16.79 per share	0.61
AXGN AxoGen	$187.34M	3.34	N/A	N/A	$2.36 per share	5.83
EDTXF Spectral Diagnostics	$1.67M	103.55	N/A	N/A	($0.07) per share	-8.64
KIDS OrthoPediatrics	$204.73M	2.12	N/A	N/A	$14.64 per share	1.22

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$392.10M	-$10.07	N/A	5.95	N/A	-66.89%	6.16%	4.57%	N/A
AXGN AxoGen	-$9.96M	-$0.10	N/A	N/A	N/A	-2.29%	-4.53%	-2.36%	N/A
EDTXF Spectral Diagnostics	-$11.24M	-$0.07	N/A	∞	N/A	-1,078.10%	N/A	-336.97%	8/8/2025 (Estimated)
KIDS OrthoPediatrics	-$37.82M	-$1.79	N/A	N/A	N/A	-18.92%	-6.35%	-4.75%	N/A

Latest EDTXF, AXGN, AVNS, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	AVNS Avanos Medical	$0.18	$0.17	-$0.01	-$1.66	$165.50 million	$175.00 million
8/5/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	-$0.11	+$0.06	-$0.30	$61.40 million	$61.08 million
5/9/2025	Q1 2025	EDTXF Spectral Diagnostics	N/A	-$0.03	N/A	-$0.03	N/A	$0.40 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
EDTXF Spectral Diagnostics	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.12	2.64	1.56
AXGN AxoGen	0.63	4.28	2.65
EDTXF Spectral Diagnostics	N/A	0.09	0.08
KIDS OrthoPediatrics	0.21	6.19	2.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
AXGN AxoGen	80.29%
EDTXF Spectral Diagnostics	N/A
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.64%
AXGN AxoGen	2.78%
EDTXF Spectral Diagnostics	1.50%
KIDS OrthoPediatrics	32.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,227	46.24 million	45.02 million	Optionable
AXGN AxoGen	450	45.54 million	44.28 million	Optionable
EDTXF Spectral Diagnostics	29	285.82 million	281.53 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable

EDTXF, AXGN, AVNS, and KIDS Headlines

Recent News About These Companies

OrthoPediatrics Highlights Strategic Focus in Presentations

49 minutes ago | theglobeandmail.com

OrthoPediatrics (NASDAQ:KIDS) Issues Earnings Results, Beats Expectations By $0.06 EPS

August 6 at 7:24 PM | marketbeat.com

OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript

August 5 at 12:10 AM | seekingalpha.com

OrthoPediatrics (KIDS) Q2 Revenue Up 16%

August 5 at 11:25 PM | fool.com

OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say

August 5 at 8:30 PM | zacks.com

OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates

August 5 at 6:45 PM | zacks.com

OrthoPediatrics Expands Specialty Bracing Division Globally

August 5 at 5:01 PM | tipranks.com

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

August 5 at 4:05 PM | globenewswire.com

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics

August 5 at 4:01 PM | globenewswire.com

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

August 4 at 4:05 PM | globenewswire.com

Universal Beteiligungs und Servicegesellschaft mbH Invests $456,000 in OrthoPediatrics Corp. (NASDAQ:KIDS)

August 4 at 3:29 AM | marketbeat.com

OrthoPediatrics (KIDS) Projected to Post Earnings on Tuesday

August 4 at 2:59 AM | americanbankingnews.com

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System for Proximal Femur Fractures and Deformities

August 1, 2025 | quiverquant.comQ

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case

August 1, 2025 | globenewswire.com

OrthoPediatrics (NASDAQ:KIDS) shareholders have endured a 53% loss from investing in the stock three years ago

July 31, 2025 | finance.yahoo.com

Here’s Why OrthoPediatrics Corp. (KIDS) Drifted Lower in Q2

July 29, 2025 | finance.yahoo.com

OrthoPediatrics (KIDS) Expected to Announce Quarterly Earnings on Tuesday

July 29, 2025 | marketbeat.com

Here’s Why OrthoPediatrics Corp. (KIDS) Drifted Lower in Q2

July 28, 2025 | insidermonkey.com

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

July 22, 2025 | globenewswire.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages

July 22, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) Downgraded by Wall Street Zen to Sell

July 19, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDTXF, AXGN, AVNS, and KIDS Company Descriptions

Avanos Medical NYSE:AVNS

$10.29 +0.40 (+4.06%)

Closing price 08/6/2025 03:59 PM Eastern

Extended Trading

$10.33 +0.04 (+0.37%)

As of 08/6/2025 06:23 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AxoGen NASDAQ:AXGN

$13.75 +0.03 (+0.22%)

Closing price 08/6/2025 04:00 PM Eastern

Extended Trading

$14.23 +0.48 (+3.49%)

As of 08/6/2025 06:08 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Spectral Diagnostics OTCMKTS:EDTXF

$0.61 -0.01 (-1.59%)

As of 08/6/2025 02:24 PM Eastern

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

OrthoPediatrics NASDAQ:KIDS

$17.90 -2.29 (-11.34%)

Closing price 08/6/2025 04:00 PM Eastern

Extended Trading

$17.86 -0.04 (-0.22%)

As of 08/6/2025 07:04 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time